3 investors at 11.2 Capital, based in New York, NY.
Back to 11.2 Capital profile
Partner, 11.2 Capital
David Dorsey is a Partner at 11.2 Capital, a venture capital firm focused on early-stage technology investments. With expertise spanning artificial intelligence, digital health, cybersecurity, robotics, and deeptech, Dorsey identifies and supports innovative companies addressing complex technical challenges. His investment portfolio includes notable successes such as Ginkgo Bioworks, a leader in synthetic biology, and Anyscale, a key player in distributed computing infrastructure. Dorsey brings a deep understanding of frontier technologies and their commercial potential, focusing on companies that leverage cutting-edge science and engineering to create significant market impact. His investment thesis emphasizes backing exceptional founders building transformative solutions in high-impact sectors where technical depth and scientific innovation drive competitive advantage.
Principal, 11.2 Capital
Pramod Gosavi is a Principal at 11.2 Capital, a venture capital firm focused on investing in transformative deep technologies. He specializes in identifying and supporting innovative companies across AI, digital health, cybersecurity, robotics, and deeptech sectors. Pramod has demonstrated strong investment acumen through notable portfolio companies including Ginkgo Bioworks, a leader in synthetic biology, and Anyscale, a prominent AI infrastructure company. His investment strategy centers on backing founders and technologies that address significant market opportunities and have the potential to create lasting impact across multiple industries. Through his work at 11.2 Capital, Pramod actively sources, evaluates, and partners with visionary entrepreneurs building the next generation of breakthrough technologies.
Founder and Managing Partner, 11.2 Capital
Shelley Zhuang is a computer scientist turned venture capitalist at 11.2 Capital who worked on search relevance and large-scale data systems at Google before investing, giving her deep technical expertise for evaluating AI, security, and infrastructure startups. She specializes in AI applications for healthcare and life sciences, focusing on how AI can improve patient care rather than just hospital operations, and emphasizes the practical challenges of data quality, privacy, and regulatory compliance when backing companies that turn complex expert judgment into scalable decision systems.
11.2 Capital's investment team consists of 3 professionals, headquartered in New York, NY. The team brings diverse backgrounds and specialized expertise to evaluate and support portfolio companies.
Across the team, 11.2 Capital's investors cover expertise in AI, Digital Health, Cybersecurity, Robotics, Deeptech. This breadth of sector knowledge enables the firm to evaluate opportunities across multiple verticals and provide specialized post-investment support to founders.
11.2 Capital has 3 investors and partners on their team, based in New York, NY. Each team member brings specialized expertise across different sectors and investment stages.
11.2 Capital's team consists of 3 investment professionals. View individual investor profiles above for detailed backgrounds, focus areas, and portfolio companies.
Newsletter
Join thousands of founders and investors. Every Tuesday.